The company’s ultimate goal is to develop a suite of solutions that allow short-RNA medicines to be delivered in a highly targeted way ... body still requiring a delivery system.

Published in July in the journal Nature Communications, the paper contends the novel technique could be generalizable, paving the road for the goal of targeted biological drug delivery.